X biocompatible polymeres
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
21.04.2015
The ASCLEPION EFFECT: Spot on for perfect skin
With the concept „THE ASCLEPION EFFECT“ Asclepion Laser Technologies aims to communicate to the users the advatages of laser technology „Made in Germany“ and to increase the well being of […]
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]